Endogenous opioids and smoking: A review of progress and problems

Psychoneuroendocrinology

Volumn 23, Issue 2, 1998, Pages 115-130

  Pomerleau, Ovide F ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Beta endorphin; Enkaphalin; Naloxone; Naltrexone; Nicotine; Opioids

Indexed keywords

AMPHETAMINE; BETA ENDORPHIN; BETA LIPOTROPIN; BUPRENORPHINE; DIAMORPHINE; ENKEPHALIN; KAPPA OPIATE RECEPTOR; METHADONE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NALTREXONE; NEUROPEPTIDE FF; NICOTINE; NICOTINE TARTRATE; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR;

ANIMAL EXPERIMENT; CIGARETTE SMOKING; CONFERENCE PAPER; DRUG SELF ADMINISTRATION; GUINEA PIG; HUMAN; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; WITHDRAWAL SYNDROME;

ANIMALS; ENDORPHINS; HUMANS; NICOTINE; NICOTINIC AGONISTS; RATS; SMOKING;

EID: 0032004327     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(97)00074-7     Document Type: Conference Paper

References (91)

1. Aceto, M. D., Acates, S. M., Ji, Z. and Bowman, E. R. (1993) Nicotine's opioid and anti-opioid interactions: proposed role in smoking behavior. European Journal of Pharmacology 248, 333-335.
2. Amir, S., Brown, Z. and Amit, Z. (1980) The role of endorphins in stress: evidence and speculations. Neuroscience and Biobehavioral Reviews 4, 77-86.
3. Arnsten, A. F. T., Berridge, C. and Segal, D. S. (1985) Stress produces opioid-like effects on investigatory behavior. Pharmacology, Biochemistry and Behavior 22, 803-809.
4. Barrett, J. E. (1983) Interrelationships between behavior and pharmacology as factors determining the effects of nicotine. Pharmacology, Biochemistry and Behavior 19, 1027-1029.
5. Battig, K. (1980) The smoking habit and psychopharmacological effects of nicotine. Activitas Nervosa Superior 22, 274-288.
6. Beaumont, A. and Hughes, J. (1979) Biology of opioid peptides. Annual Review of Pharmacology and Toxicology 19, 245-267.
7. Biagini, R. E., Klincewicz, S. L., Kenningsen, G. M., MacKenzie, B. A., Gallagher, J. S., Bernstein, D. I. and Berstein, I. L. (1990) Antibodies to morphine in workers exposed to opiates at a narcotics manufacturing facility and evidence for similar antibodies in heroin abusers. Life Sciences 47, 897-908.
8. Calogero, A. E., Galucci, W. T., Bernardini, R., Saoutis, C., Gold, P. W. and Chrousos, G. P. (1988) Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. Neuroendocnnology 47, 303-308.
9. Carrera, M. R. A., Ashley, J. A., Parsons, L. H., Wirsching, P., Koob, G. F. and Janda, K. D. (1995) Suppression of psychoactive effects of cocaine by active immunization. Nature 378, 727-730.
10. Chait, L. D. and Griffiths, R. R. (1984) Effects of methadone on human cigarette smoking and subjective ratings. Journal of Pharmacology and Experimental Therapeutics 229, 636-640.
11. Conte-Devolx, B., Oliver, C., Giraud, P., Gillioz, P., Castanas, E., Lissitsky, J. C., Boudouresque, F. and Millet, Y. (1981) Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat. Life Sciences 28, 1067-1073.
12. Corrigall, W. A. and Coen, K. M. (1991) Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104, 167-170.
13. Corrigall, W. A., Herling, S. and Coen, K. M. (1988) Evidence for opioid mechanisms in the behavioral effects of nicotine. Psychopharmacology 96, 29-35.
14. Davenport, K. E., Houdi, A. A. and Van Loon, G. R. (1990) Nicotine protects against mu-opioid receptor antagonism by beta-fur altrexamine: evidence for nicotine-induced release of endogenous opioids in brain. Neuroscience Letters 113, 40-46.
15. Dawe, S., Gerada, C., Russell, M. A. H. and Gray, J. A. (1995) Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology 117, 110-115.
16. Dobbs, S. D., Strickler, D. P. and Maxwell, W. E. (1981) The effects of stress and relaxation in the presence of stress on urinary pH and smoking behavior. Addictive Behaviors 6, 345-353.
17. Fertig, J. B., Pomerleau, O. F. and Sanders, B. (1986) Nicotine-produced antinociception in minimally deprived smokers and ex-smokers. Addictive Behaviors 11, 239-249.
18. Gilbert, D. G. (1979) Paradoxical tranquilizing and emotion-reducing effects of nicotine. Psychological Bulletin 86, 643-661.
19. Gilbert, D. G., Meliska, C. J., Williams, C. L. and Jensen, R. A. (1992) Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol. Psychopharmacology 106, 275-281.
20. Goldstein, A. (1994) Addiction: From Biology to Drug Policy. W. H. Freeman, New York.
21. Gorelick, D. A., Rose, J. and Jarvik, M. E. (1989) Effect of naloxone on cigarette smoking. Journal of Substance Abuse 1, 153-159.
22. Henningfield, J. E. (1984) Pharmacologic basis and treatment of cigarette smoking. Journal of Clinical Psychiatry 45, 24-34.
23. Henningfield, J. E. and Goldberg, S. R. (1983) Control of behavior by intravenous nicotine injections in human subjects. Pharmacology, Biochemistry and Behavior 19, 1021-1026.
24. Hexum, T. D. and Russett, L. R. (1987) Plasma enkephalin-like peptide response to chronic nicotine infusion in guinea pig. Brain Research 406, 370-372.
25. Holaday, J. W. (1985) Endogenous Opioids and their Receptors: Current Concepts. Upjohn Company, Kalamazoo, MI.
26. Hollt, V. and Horn, G (1989) Nicotine and opioid peptides. In Progress in Brain Research, eds A. Nordberg, K. Fuxe, B. Holmstedt and A. Sundwall, Vol. 79, pp. 187-193. Elsevier/North Holland Biomedical Press, Amsterdam.
27. Houdi, A. A., Pierzchala, K., Marson, L., Palkovitz, M. and Van Loon, G. R. (1991) Nicotine-induced alteration in Tyr-Gly Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity. Peptides 12, 161-166.
28. Huston-Lyons, D. and Kornetsky, C. (1992) Effects of nicotine on the threshold for rewarding brain stimulation in rats. Pharmacology, Biochemistry and Behavior 41, 755-759.
29. Huston-Lyons, D., Sarkar, M. and Kornetsky, C. (1993) Nicotine and brain-stimulation reward: interactions with morphine, amphetamine and pimozide. Pharmacology, Biochemistry and Behavior 46, 453-457.
30. Hutchison, K. E., Collins, F. L., Tassey, J. and Rosenberg, E. (1996) Stress, naltrexone, and the reinforcement value of nicotine. Experimental and Clinical Psychopharmacology 4, 431-437.
31. Izquierdo, I., Dias, R. D., Souza, S. O., Carrasco, M. A., Elisabetsky, E. and Perry, M. L. (1980) The role of opioid peptides in memory and learning. Behavior and Brain Research 1, 451-468.
32. Jarvik, M. E., Caskey, N. H., Rose, J. E., Herskovic, J. E. and Sadeghpour, M. (1989) Anxiolytic effects of smoking associated with four Stressors. Addictive Behaviors 14, 379-386.
33. Jaffe, A. J., Rounsaville, B., Chang, G., Schottenfeld, R. S., Meyer, R. E. and O'Malley, S. S. (1996) Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. Journal of Consulting and Clinical Psychology 64, 1044-1053.
34. Jaffe, J. H. (1975) Drug addiction and drug abuse. In The Pharmacological Basis of Therapeutics, eds L. S. Goodman and A. Gilman, 5th edn, p. 317. Macmillan Publishing.
35. Karras, A. and Kane, J. M. (1980) Naloxone reduces cigarette smoking. Life Sciences 27, 1541-1545.
36. Koop, C. E. (1988) Nicotine addiction: The health consequences of smoking (1988 Report of the Surgeon General of the United States). Public Health Service, Washington DC.
37. Kozlowski, L., Wilkinson, A., Skinner, W., Kent, C., Franklin, T. and Pope, M. (1989) Comparing tobacco cigarette dependence with other drug dependencies. JAMA 261, 898-901.
38. Le Dain, A. C., Madsen, B. W. and Edeson, R. O. (1991) Naltrexone modulation of nicotinic acetylcholine receptor activity. Journal of Pharmacology and Experimental Therapeutics 258, 551-558.
39. Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S. and Wilson, O. B. (1992) A rodent model of nicotine abstinence syndrome. Pharmacology, Biochemistry and Behavior 43, 779-784.
40. Malin, D. H., Lake, J. R., Payne, M. C., Short, P. E., Carter, V. A., Cunningham, J. S. and Wilson, O. B. (1996a) Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversable. Pharmacology, Biochemistry and Behavior 53, 81-85.
41. Malin, D. H., Lake, J. R., Short, P. E., Blossman, J. B., Lawless, B. A., Schopen, C. K., Sailer, E. E., Burgess, K. and Wilson, O. B. (1996b) Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF. Pharmacology, Biochemistry and Behavior 54, 581-585.
42. Margules, D. (1979) Beta-endorphin and endoloxone: hormones of the autonomic nervous system for the conservation or expenditure of bodily resources and energy in anticipation of famine or fast. Neuroscience and Biobehavioral Reviews 3, 155-162.
43. Marty, M. Y., Erwin, V. G., Cornell, K. and Zgombick, J. M. (1985) Effects of nicotine on beta-endorphin, alpha-MSH, and ACTH secretion by isolated perfused mouse brains and pituitary glands, in vitro. Pharmacology, Biochemistry and Behavior 22, 317-325.
44. McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P. and Role, L. W. (1995) Nicotine enhancement of fast excitary synaptic transmission in CNS by presynaptic receptors. Science 269, 1692-1696.
45. Meliska, C. J. and Gilbert, D. G. (1991) Hormonal and subjective effects of smoking the first five cigarettes of the day: a comparison in males and females. Pharmacology, Biochemistry and Behavior 40, 229-235.
46. Mello, N. K., Lukas, S. E. and Mendelson, J. H. (1985) Buprenophine effects on cigarette smoking. Psychopharmacology 86, 417-425.
47. Mello, N. K., Mendelson, J. H., Sellers, M. L. and Kuehnle, J. C. (1980) Effects of heroin self-administration on cigarette smoking. Psychopharmacology 67, 45-52.
48. Mendelson, J. H., Ellingboe, J., Kuehnle, J. C. and Mello, N. K. (1980) Heroin and naltrexone effects on pituitary gonadal hormones in man: interaction of steroid feedback effects, tolerance and supersensitivity. Journal of Pharmacology and Therapeutics 214, 503-506.
49. Millan, M. J. (1981) Stress and endogenous opioid peptides: a review. Modern Problems in Pharmacopsychiatry 17, 49-67.
50. Millan, M. and Emrich, H. (1981) Endorphinergic systems and the response to stress. Psychotherapy and Psychosomatics 36, 43-56.
51. Morse, D. E. (1989) Neuroendocrine responses to nicotine and stress: enhancement of peripheral stress response by the administiation of nicotine. Psychopharmacology 98, 539-543.
52. Munck, A., Guyre, P. M. and Holbrook, N. K. (1984) Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Reviews 5, 25-44.
53. Myrsten, A. L., Andersson, K., Frankenhauser, M. and Elgerot, A. (1975) Immediate effects of cigarette smoking as related to different smoking habits. Perceptual and Motor Skills 40, 515-523.
54. Nemeth-Coslett, R., Henningfield, J. E., O'Keefe, M. K. and Griffiths, R. R. (1986) Effects of mecamylamine on human cigarette smoking and subjective ratings. Psychopharmacology 88, 420-425.
55. Palmer, R. F. and Berens, A. (1983) Double-blind study of the effect of naloxone on the pleasure of smoking. Federation Proceedings 42, 654.
56. Perkins, K. A., Grobe, J. E., Stiller, R. L., Scierka, A., Goettler, J., Reynolds, W. and Jennings, J. R., (1994) Experimental and Clinical Psychopharmacology 2, 95-106.
57. Pierzchala, K., Houdi, A. A. and Van Loon, G. R. (1987) Nicotine-induced alterations in brain regional concentrations of native and cryptic met- and leu-enkephalin. Peptides 8, 1035-1043.
58. Pomerleau, O. F. (1986) Nicotine as a psychoactive drug: anxiety and pain reduction. Psychopharmacology Bulletin 22, 863-883.
59. Pomerleau, O. F. (1995) Individual differences in sensitivity to nicotine: implications for genetic research on nicotine dependence. Behavior Genetics 25, 161-177.
60. Pomerleau, O. F. and Pomerleau, C. S. (1984) Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Neuroscience and Biobehavioral Reviews 8, 503-513.
61. Pomerleau, C. S. and Pomerleau, O. F. (1987) The effects of a psychological stressor on cigarette smoking and on subsequent behavioral and physiological response. Psychophysiology 24, 278-285.
62. Pomerleau, C. S., Pomerleau, O. F. and Majchrzak, M. J. (1987) Mecamylamine pretreatment increases subsequent nicotine self-administraion as indicated by changes in plasma nicotine level level. Psychopharmacology 91, 391-393.
63. Pomerleau, O. F. and Pomerleau, C. S. (1990) Cortisol response to a psychological stressor and/or nicotine. Pharmacology, Biochemistry and Behavior 36, 211-213.
64. Pomerleau, O. F. and Pomerleau, C. S. (1991) Research on stress and smoking: progress and problems. British Journal of Addiction 86, 599-603.
65. Pomerleau, C. S. and Pomerleau, O. F. (1992) Euphoriant effects of nicotine in smokers. Psychopharmacology 108, 460-465.
66. Pomerleau, O. F. and Pomerleau, C. S. (1994) Euphoriant effects of nicotine. Tobacco Control 3, 374.
67. Pomerleau, O. F. and Rosecrans, J. (1989) Neuroregulatory effects of nicotine. Psychoneuroendocrinology 14, 407-423.
68. Pomerleau, O. F., Adkins, D. and Pertschuk, M. (1978) Predictors of outcome and recidivism in smoking cessation treatment. Addictive Behaviors 3, 65-70.
69. Pomerleau, O. F., Fertig, J. B., Seyler, L. E. and Jaffe, J. (1983) Neuroendocrine reactivity to nicotine in smokers. Psychopharmacology 81, 61-67.
70. Pomerleau, O. F., Turk, D. and Fertig, J. B. (1984) The effects of cigarette smoking on pain and anxiety. Addictive Behavior 9, 265-271.
71. Risch, S. C., Janowsky, D. S., Siever, L. J., Judd, L. J., Rausch, J. L., Huey, L. Y., Beckman, K. A., Cohen, R. M. and Murphy, D. L. (1982) Correlated cholinomimetic-stimulated beta-endorphin and prolactin release in humans. Peptides 3, 310-322.
72. Robinson, T. E. and Berridge, K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research Reviews 18, 247-291.
73. Rose, J. E., Ananda, S. and Jarvik, M. E. (1983) Cigarette smoking during anxiety-provoking and monotonous tasks. Addictive Behaviors 8, 353-359.
74. Rosecrans, J. A. (1971) Effects on nicotine on behavioral arousal and brain 5-hydroxytryptamine function in female rats selected for differences in activity. European Journal of Pharmacology 14, 29-37.
75. Rosecrans, J. A., Hendry, J. S. and Hong, J. S. (1985) Biphasic effects of chronic nicotine treatment on hypothalamic immunoreactive beta-endorphin in the mouse. Pharmacology, Biochemistry and Behavior 23, 141-143.
76. Rothman, R. B., Xu, H., Yang, H. Y. T. and Long, J. B. (1993) Anti-opioid peptides in morphine tolerance and dependence: focus on NPFF. In The Neurobiology of Opiates, ed. R. P. Hammer, pp. 147-163. CRC Press, Boca Raton.
77. Sahley, T. and Berntsen, G. (1979) Antinociceptive effects of central and systemic administration of nicotine in the rat. Psychopharmacology 65, 279-283.
78. Schachter, S. (1978) Pharmacological and psychological determinants of smoking. Annals of Internal Medicine 88, 104-114.
79. Schmitz, J. M., Grabowski, J. and Rhodes, H. (1994) The effects of high and low doses of methadone on cigarette smoking. Drug and Alcohol Dependence 34, 237-242.
80. Seyler, L. E., Pomerleau, O. F., Fertig, J. B., Hunt, D. and Parker, K. (1986) Pituitary hormone response to cigarette smoking. Pharmacology, Biochemistry and Behavior 24, 159-162.
81. Shiffman, S. (1982) Relapse following smoking cessation: a situational analysis. Journal of Consulting and Clinical Psychology 50, 71-86.
82. Silvette, H., Hoff, E. C., Larson, P. S. and Haag, H. B. (1962) The actions of nicotine on central nervous system functions. Pharmacological Reviews 14, 137-173.
83. Sloane, J. W., Martin, W. R. and Bostwick, M. (1989) Mechanisms involved in the respiratory depressant actions of nicotine in anesthetized rats. Pharmacology, Biochemistry and Behavior 34, 559-564.
84. Sutherland, G., Stapleton, J. A., Russell, M. A. H. and Feyerabend, C. (1995) Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology 120, 418-425.
85. Tobin, M. J., Jenouri, G. and Sackner, M. A. (1982) Effects of naloxone on change in breathing pattern with smoking. Chest 82, 530-537.
86. Tripathi, J., Martin, B. and Aceto, M. (1982) Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels. Journal of Pharmacology and Experimental Therapeutics 221, 91-96.
87. van Ree, J. M. and de Wied, D. (1981) Brain peptides and psychoactive drug effects. In Research Advances in Alcohol and Drug Problems, eds. Y. Israel, F. Glaser, H. Kalant, R. Popham, W. Schmidt and R. Smart, Vol. 6, pp. 67-105. Plenum Press, New York.
88. Wewers, M. E., Tejwani, G. A. and Anderson, J. (1994) Plasma nicotine, plasma beta-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement. Psychopharmacology 116, 98-102.
89. Widenfeld, J., Siegel, R., Conforti, N., Mizrachi, R. and Brenner, T. (1983) Effect of intracerobroventricular injection of nicotine acetyl receptor antibodies on ACTH, corticosterone and prolactin secretion in the male rat. Brain Research 265, 152-156.
90. Yang, H. Y. T., Fratta, W., Majane, E. A. and Costa, E. (1985) Isolation sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proceedings of the National Academy of Sciences USA 82, 7757-7761.
91. Wise, R. A. and Bozarth, M. A. (1987) A psychomotor stimulant theory of addiction. Psychological Reviews, 94, 469-492.